about
Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significanceTumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2BMP-2 overexpression augments vascular smooth muscle cell motility by upregulating myosin Va via Erk signaling.The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.Adiponectin resistance and vascular dysfunction in the hyperlipidemic stateThioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actionsSystemic adiponectin malfunction as a risk factor for cardiovascular diseaseReduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathwayAging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and ratsAMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action.Triage during the week of the Sichuan earthquake: a review of utilized patient triage, care, and disposition procedures.The dragon strikes: lessons from the Wenchuan earthquake.Estradiol pretreatment attenuated nicotine-induced endothelial cell apoptosis via estradiol functional membrane receptor.Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury.Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients.Up-regulation of heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability.Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury.Increased susceptibility to metabolic syndrome in adult offspring of angiotensin type 1 receptor autoantibody-positive rats.Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells.Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis.Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice.Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosisAdvanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cellsA patient with a large pulmonary saddle embolus eluding both clinical gestalt and validated decision rulesDynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic miceThe alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury
P50
Q26865140-C5D9A68D-74E7-41EB-94CE-54C65B6C7ED4Q28488447-E4C966C6-377C-4542-BF52-DF519B8B82FAQ29347091-C0DB33D5-5B08-48A2-BEBA-8161C20247C4Q33506186-E477AD8B-C72B-4FE5-9F24-34954CB6FEA3Q33577630-8EFA949F-76CC-44DB-9651-5372A5906027Q33976920-32DF810B-51BD-42A1-B42A-68E880945728Q35173604-120E68CD-AFD9-418B-8FBD-879E89BE6BCAQ35173617-5E947CCE-CE02-47A4-BEAD-B14FCF202377Q35401905-3CCA5BD7-7217-4D99-8A45-F5DEB3DE3F70Q36993316-E2768894-20C7-4C72-9B25-E11BBF6C78B5Q37135564-AE01ADFF-9581-470F-AE33-C452498D4B28Q37291297-A47C499D-C5D2-45B6-B44F-2977F590CC19Q37298116-49CC9314-A935-4A96-826F-772E1DD55DCBQ37691944-EC4CE86E-4B41-456F-8278-0EB587E53891Q39290534-92470E0E-7F48-4C6E-A68D-AC936B1860BAQ39603809-A056EA31-C976-4279-B8BE-28D5D35AA2AEQ43055444-4910F495-5085-40B0-8A43-8C071C61ACCCQ43086341-F66082B9-8F0B-4E32-A67C-A8E34FE2DF70Q43504116-BDB5E5E1-BC5D-4580-95FA-440F65D7D179Q44150231-83D9E016-4598-41D2-8C52-678CA12A04F1Q51039287-2CDD1E14-AB6C-4914-A6BC-46D5DEE0E091Q51361582-29D2703C-80A7-4E9F-A2F7-C1817B6E3AFEQ54503417-20C167AF-54DA-4E1D-976D-2EE3982FB613Q55403102-95FC94A7-3AE4-44FB-A443-E4B5A90FDD89Q64936967-ED88D470-6F8F-4181-997F-A9BB08ED69C0Q80243791-83E16A3A-39AF-48F8-9BB9-9D24405EDDD2Q82708853-433B842A-31C9-4932-8D02-F8F6534F4A05Q82871535-A2E68B90-EB7F-4F64-B053-C92EE208B657Q84131946-290EBE16-25FE-4499-BA8F-A37AB56F65DEQ84616145-4219783F-AC26-4752-8D1C-6ADC374672B3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wayne Bond Lau
@ast
Wayne Bond Lau
@en
Wayne Bond Lau
@es
Wayne Bond Lau
@nl
Wayne Bond Lau
@sl
type
label
Wayne Bond Lau
@ast
Wayne Bond Lau
@en
Wayne Bond Lau
@es
Wayne Bond Lau
@nl
Wayne Bond Lau
@sl
prefLabel
Wayne Bond Lau
@ast
Wayne Bond Lau
@en
Wayne Bond Lau
@es
Wayne Bond Lau
@nl
Wayne Bond Lau
@sl
P106
P1153
14630794400
P31
P496
0000-0002-8064-8290